U.S. markets open in 7 hours 43 minutes

Citrine Global Corp. (CTGL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1490-0.0010 (-0.67%)
At close: 2:57PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1500
Open0.1365
BidN/A x N/A
AskN/A x N/A
Day's Range0.1230 - 0.1490
52 Week Range0.0300 - 0.3700
Volume6,291
Avg. Volume36,149
Market Cap140.443M
Beta (5Y Monthly)0.79
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateJun 15, 2020 - Jun 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Citrine Global Corp. (OTCQB: CTGL) is Glad to Announce Cannovation Center Israel Ltd. Won Israeli Government Grant to Acquire 10,000 sqm of Industrial Land for Building the Cannovation Center Israel in Yeruham's Biopharma Park
    GlobeNewswire

    Citrine Global Corp. (OTCQB: CTGL) is Glad to Announce Cannovation Center Israel Ltd. Won Israeli Government Grant to Acquire 10,000 sqm of Industrial Land for Building the Cannovation Center Israel in Yeruham's Biopharma Park

    Citrine Global Corp. views Cannovation Center Israel winning the Israeli Government Ministry of Economy grant and Yeruham Local Council support as an important strategic step in establishing the Cannovation Center Israel, which is planned to be the first operational innovation center that includes factories, laboratories, logistics, and a distribution center for the medical cannabis, CBD, hemp and botanical industriesTel Aviv, Jan. 05, 2021 (GLOBE NEWSWIRE) -- On December 30, 2020, Cannovation Center Israel Ltd. won Israeli Government Ministry of Economy grant to acquire 10,000 square meters (2.5 acres) of industrial land to build the Cannovation Center Israel at the Biopharma Park in Yeruham.The Cannovation Center Israel is a unique platform that includes factories for the production of medical cannabis, botanicals, CBD, hemp, supplements, food, and cosmetic products; laboratories for quality assurance, research, development, and clinical trials; a logistics, distribution, import and export center; business development strategy services.Cannovation Center Israel Ltd. is 60%-owned by CTGL - Citrine Global Israel Ltd., which is a wholly-owned subsidiary of Citrine Global Corp. (collectively, the “Citrine Global Group”). Citrine Global Group views the establishment of the Cannovation Center Israel as a national project backed by grants and support from the Israeli government and the Yeruham local council, and is aiming to create an ecosystem and collaborations between companies, entrepreneurs, universities and partners from Israel and around the world.Ora Elharar Soffer, CEO, Citrine Global Corp.: "We are proud to be the ones to establish the first operational innovation center of its kind for cannabis in the Biopharma Park in Yeruham with the support of the Israeli government and Yeruham Local Council and take part in the realization of Tal Ohana's vision to turn Yeruham into the capital of medical cannabis. The Cannovation Center Israel will provide a comprehensive operational solution tailored to the requirements of the cannabis and botanical industry and is an important milestone that combines production, operations, technologies, and business development to leverage local and international collaborations. According to our strategy, we plan to build additional operational innovation centers working in this business model around the world."Tal Ohana, Mayor of Yeruham: "We have been working with Ora Elharar Soffer and the Citrine Global Group and welcome the establishment of the innovative Cannovation Center Israel in the Biopharma Park in Yeruham. Our vision to turn Yeruham into the medical cannabis capital, through the Green-Negev project which I have been leading in the last few years, is becoming a reality. We receive support from the Israeli government and leading companies and entrepreneurs. In the last year, we have established a start-up incubator for cannabis technologies with the assistance of the Innovation Authority and in partnership with the pharmaceutical company Perrigo, which has a factory in Yeruham, and with Israeli Cannabis Company BOL. The incubator is already active, and the expected volume of investments is NIS 150 million for the operation of the incubator in the coming years. In addition, we received approval from the Ministry of Economy to allocate land and support factories' construction, which includes a 30% return on investment in the construction of the factory, a subsidized industrial area, reduced corporate tax, subsidy for senior employees' salaries, and more."About Citrine Global Corp., CTGL - Citrine Global Israel Ltd. and Cannovation Center Israel Ltd.Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) operates in Israel through its wholly owned subsidiary, CTGL - Citrine Global Israel Ltd. ("Citrine Global Israel"), which focuses on Israeli technologies in the fields of healthcare, wellness, foodtech and medical cannabis.Citrine Global recognized the need for innovation centers in the medical cannabis and the food tech industries and decided to establish the first center in Israel in the field of cannabis through Cannovation Center Israel Ltd.Citrine Global develops strategic solutions for technology industries with global growth potential in the high-tech and biotech fields, which include supportive environments that combine, among other things, entrepreneurship and the establishment of innovation centers for production, operations, R&D, marketing, export, assistance in building strategy for realizing the potential, and more.For more information about Citrine Global: http://www.citrine-global.comFor inquiries and further information, please contact: info@citrine-global.comSafe Harbor StatementThis press release contains express or implied forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securities laws. For example, Citrine Global is using forward-looking statements in respect to viewing the establishment of the Cannovation Center Israel as a national project backed by grants and support from the Israeli government and the Yeruham local council, its intent to establish an innovation and operations center in Yeruham, the anticipation that the Cannovation Center Israel will provide a comprehensive operational solution tailored to the requirements of the cannabis and botanical industry and is an important milestone that combines production, operations, technologies and business development to leverage local and international collaborations and the expected volume of investments of NIS 150 million for Yeruham’s start-up incubator for cannabis technologies for the operation of the incubator in the coming years. These forward-looking statements and their implications are based on the current expectations of the management of Citrine Global only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include, but are not limited to: trends in target markets; effects of competition in the Company's main markets; ability to establish and maintain strategic relationships in its major businesses; profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and regulatory forces. Except as otherwise required by law, Citrine Global undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Citrine Global, reference is made to Citrine Global’s reports filed from time to time with the Securities and Exchange Commission.

  • Citrine Global Israel and Ms. Tal Ohana, Mayor of Yeruham in the South of Israel, are Promoting an Innovation Center to be Established in Yeruham's Biopharma Park by Cannovation Center Israel Ltd.
    GlobeNewswire

    Citrine Global Israel and Ms. Tal Ohana, Mayor of Yeruham in the South of Israel, are Promoting an Innovation Center to be Established in Yeruham's Biopharma Park by Cannovation Center Israel Ltd.

    Cannovation Center Israel platform integrates everything needed to promote the medical cannabis industry and CBD & hemp-infused products and botanicals and will be a big step towards fulfilling the vision of Ms. Tal Ohana Yeruham's mayor of turning Yeruham into a medical cannabis research, technology and production capital Tel Aviv, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) -- CTGL - Citrine Global Israel Ltd. (“Citrine Global Israel”) and Ms. Tal Ohana, Mayor of Yeruham, are working to establish the Cannovation Center Israel in the South of Israel in Yeruham's Biopharma Park. Cannovation Center Israel will include factories for medical cannabis products, CBD , hemp, food, nutritional supplements, and cosmetics; laboratories for production, research & development, and clinical trials; a center for logistics, distribution, import, export, and more. Cannovation Center Israel Ltd. is in the process of getting Israeli government support for the project.Citrine Global Israel views Cannovation Center Israel as a national project, which it believes will be a leading manufacturing, operational and research center and will bring together technologies, partners, and companies from Israel and around the world.Tal Ohana, Mayor of Yeruham: "GreeNegev vision, the first cannabinoid ecosystem in Israel, is already a reality in Yeruham. Within one year we established a technological incubator in the cannabis field with expected investments of over 150 million NIS in partnership with leading international companies; we prepared agricultural and industrial areas adapted for cannabis growing and innovative cannabis-based products approved by the Israeli Ministry of Economy; we built an academic partnership for training and will soon recruit young entrepreneurs from Israel and around the world to take part in a unique technology accelerator. We have been working with Ora and Citrine for several years and the Cannovation Center Israel will leverage our activity in Israel and abroad".Ora Elharar Soffer, CEO of Citrine Global, Corp.: “We believe in our unique innovation centers' platform, which creates ecosystems for innovative technology industries with global growth potential. We recognized the existing need for innovation centers in the medical cannabis and food tech industries in Israel and decided to establish Cannovation Center Israel in Yeruham. We believe in Ms. Tal Ohana's vision and look forward to a fruitful cooperation. Cannovation Center Israel will enhance collaboration between entrepreneurs, universities and companies from all over the world and the companies and partners participating in the center, thus contributing to Yeruham's success".About Citrine Global Corp., CTGL - Citrine Global Israel Ltd. and Cannovation Center Israel Ltd. Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) develops strategic solutions for emerging technology industries with global growth potential in the high-tech and biotech fields. The company has solutions that combine supportive environments that include among others: * Entrepreneurship and establishment of innovation centers for production, operations, R&D, marketing, import, export, and more. * Financing and investments, with Citrine team being involved and assisting in building the strategy for realizing the potential in the field.Citrine Global's innovation center strategy is a unique platform for building an ecosystem for innovative technology industries with global growth potential.The goal is that each innovation center will focus on a major field, creating synergy between companies and providing an operational solution that includes manufacturing, research and development, labs, clinical trials, a logistics center, distribution, import, export, and more.The companies that will participate in the innovation centers will also be able to benefit from assistance in building strategy, financing, investments, and collaboration between entrepreneurs, universities, and companies from all over the world.Citrine Global Corp operates in Israel through its subsidiary, CTGL - Citrine Global Israel Ltd., focusing on Israeli technologies in the industries of healthcare, wellness, food technology and medical cannabis. Citrine Global recognized the existing need for innovation centers in the medical cannabis and food tech industries in Israel and decided to establish the first medical cannabis innovation center in Israel via Cannovation Center Israel Ltd.For more information about Citrine Global: http://www.citrine-global.comFor inquiries and further information, please contact: info@citrine-global.comSafe Harbor StatementThis press release contains express or implied forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securities laws. For example, Citrine Global is using forward-looking statements when it discusses its intent to promote, with the Yeruham Local Council, a vision to turn the city of Yeruham into a medical cannabis powerhouse, its intent to establish an innovation and operations center in the city of Yeruham, the anticipation that the Cannovation Center will bring together companies, factories, and partners from Israel and around the world, the likelihood of receiving support and the required approvals from the Israeli government offices to establish the Cannovation Center and expected investments of over 150 million NIS in partnership with leading international companies in the city of Yeruham. These forward-looking statements and their implications are based on the current expectations of the management of Citrine Global only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include, but are not limited to: trends in target markets; effects of competition in the Company's main markets; ability to establish and maintain strategic relationships in its major businesses; profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and regulatory forces. Except as otherwise required by law, Citrine Global undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Citrine Global, reference is made to Citrine Global’s reports filed from time to time with the Securities and Exchange Commission.

  • GlobeNewswire

    Citrine Global, Corp. Applies to List its Common Stock on Nasdaq

    Tel Aviv, Israel, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Citrine Global, Corp. (OTCQB: CTGL) is pleased to announce that it has applied to list its common stock on the Nasdaq Capital Market. The proposed listing on Nasdaq is subject to several regulatory requirements and a determination by Nasdaq that the company has satisfied all applicable listing requirements, including, but not limited to, shareholder’s equity requirements, a sufficient price per share and a sufficient number of round lot holders. There is no guarantee that the Company will be successful in obtaining the necessary approvals to list its common stock on Nasdaq. Until such time as such Nasdaq approval for listing is obtained, the common stock will continue to trade on the OTCQB under "CTGL". As part of the company's preparations to meet the Nasdaq listing requirements, on October 8, 2020, the board of directors approved a reverse stock split of the company's authorized, issued, and outstanding shares of common stock, subject to stockholder approval, with the final ratio of this step to be determined by the board at a later date.We believe that the requested listing on Nasdaq is a strategic stage in Citrine Global's growth targeted to potentially enlarge the company's investor base and establish its position as a global brand. Citrine Global remains focused on executing the company's strategic business plan creating value for its stockholders.About Citrine Global Corp.Citrine Global, Corp. provides industry-wide solutions for innovative technologies, empowering the healthcare and wellness eco-systems to prosper by offering solutions and creating environments that inspire progress and growth. The multi-strategy solutions include financing, entrepreneurship, and business real-estate facilities.Citrine Global, Corp. operates in the Israeli market via its subsidiaries CTGL - Citrine Global Israel Ltd. and Cannovation Center Israel Ltd., targeting the Israeli healthcare, wellness, food tech and medical cannabis industries.The Cannovation Center business model is a unique, all-in-one platform, which is planned to have factories for producing medical cannabis, hemp, and botanical products; laboratories for production, research and development and clinical trials; and recycling, logistics, and an import/export distribution center. It is designed to support the medical cannabis eco-system, which requires interdisciplinary expertise and compliance with a wide set of regulations.The Cannovation Center is planned to be built with Israeli government support, leveraging Israel’s leadership in cannabis innovation, and combine partners and companies from Israel and worldwide.For more information about Citrine Global: https://www.otcmarkets.com/stock/CTGL/overview https://youtu.be/52QbgGCKRAEWebsite: http://www.citrine-global.comFor inquiries and further information, please contact: info@citrine-global.comSafe Harbor Statement This press release contains express or implied forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S. Federal securities laws. For example, Citrine Global is using forward-looking statements when it discusses its intent to conduct a reverse stock split, subject to stockholder approval, its intention to list its common stock on the Nasdaq Capital Market and its belief that the proposed Nasdaq listing is a strategic stage in its growth targeted to potentially enlarge its investor base and establish its position as a global brand. These forward-looking statements and their implications are based on the current expectations of the management of Citrine Global only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause actual results to differ materially from those estimated by the forward-looking statements contained in this communication include, but are not limited to: trends in target markets; effects of competition in the Company's main markets; ability to establish and maintain strategic relationships in its major businesses; profitability of the growth strategy; and changes in global, political, economic, business, competitive, market and regulatory forces. Except as otherwise required by law, Citrine Global undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Citrine Global, reference is made to Citrine Global’s reports filed from time to time with the Securities and Exchange Commission.